20160128 EGA Regulatory and Scientific Affairs Conferenc

Billions more euros to re-invest in better healthcare thanks to biosimilar medicines

13 December 2022

Read More

Pharmaceutical legislation reforms must support equitable access to medicine in Central and Eastern Europe and security of medicines supplies

16 November 2022

Read More

Proposals on wastewater treatment will jeopardise patient access to medicines without helping green transition

26 October 2022

Read More

Rapid policy action needed to protect patient access to essential medicines as inflation bites

12 October 2022

Read More

EU pharmaceutical legislation reform critical to sustain biosimilar medicines competition for the future

6 October 2022

Read More

Updated Guide to empower nurses managing patients on biological therapies

3 October 2022

Read More

EMA/HMA share definitive EU-wide position on biosimilar medicines interchangeability

19 September 2022

Read More

Medicines for Europe warns strongly against energy rationing for medicines production

20 July 2022

Read More

The Supplementary Protection Certificate (SPC) manufacturing waiver becomes operational!

1 July 2022

Read More

The off-patent medicines industry is a vital part of the solution for healthcare resilience

30 June 2022

Read More

Subscribe to our newsletter

[contact-form-7 id="1638" title="Newsletter subscription"]